ANH MA: Open Payments
NPI 1982116018 · TOMBALL, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$620 in 27 payments from 7 companies in 2025. Trend: 2023 $280 · 2024 $473 · 2025 $620
Food & beverage: $620
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 6 | $146 |
| Abbott Laboratories | 4 | $139 |
| Novo Nordisk Inc | 7 | $132 |
| Merck Sharp & Dohme LLC | 6 | $122 |
| Actelion Pharmaceuticals US, Inc. | 2 | $40 |
| ABIOMED | 1 | $28 |
| Amgen Inc. | 1 | $14 |
Products named: LEQVIO, VERQUVO, Wegovy, JOT DX, CARDIOMEMS, OPSUMIT, CAPVAXIVE, Ozempic.
Industry payments across TX — which companies pay providers there.
